UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Allergan to compensate breast implant recipients for damage
Allergan agreed to provide full compensation for the medical expenses of pa...
by Lee Hye-seon
|
2019-09-30 15:33
라인
Ranitidine recall taking heavy toll on pharmaceuticals
Pharmaceutical companies are expected to suffer massive losses due to the r...
by Jeong Sae-im
|
2019-09-30 15:16
라인
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
The Ministry of Food and Drug Safety has suspended the sale of Novartis Kor...
by Lee Hye-seon
|
2019-09-30 11:25
라인
Drug regulator under fire for going too far, too late
The Ministry of Food and Drug Safety (MFDS)'s ability and credibility a...
by Lee Han-soo
|
2019-09-27 17:48
라인
Investor trust in bio-industrialists sank due to latter’s unethical acts
The biotech industry is losing trust from investors as some executives at t...
by Lee Han-soo
|
2019-09-27 15:11
라인
Foreign trainees satisfied with Lee Jong-wook Fellowship
The Lee Jong-wook Fellowship is receiving favorable feedback from trainees ...
by Choi Gwang-seok
|
2019-09-27 15:05
라인
Regulator explained why it banned stomach medicine ranitidine altogether
The Ministry of Food and Drug Safety Thursday offered a briefing to pharmac...
by Jeong Sae-im
|
2019-09-27 15:02
라인
Samsung Bioepis releases P3 results of Bevacizumab biosimilar in EU
Samsung Bioepis has presented the results of phase 3 study clinical evaluat...
by Lee Han-soo
|
2019-09-27 11:37
라인
Genexine sets up joint firm in Thailand
Genexine said that it has established KinGen Biotech in Thailand, a joint v...
by Lee Han-soo
|
2019-09-26 17:00
라인
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
The recent failures by Korean biotech companies to reach meaningful results...
by Lee Han-soo
|
2019-09-26 15:39
라인
‘Samsung BioLogics destroyed evidence to hide accounting fraud for months’
Executives of Samsung BioLogics and affiliated companies claimed that they ...
by Jeong Sae-im
|
2019-09-26 15:24
라인
Celltrion to start marketing Herzuma in Middle East
Celltrion Healthcare said that it won the bid to sell Herzuma, an anticance...
by Lee Han-soo
|
2019-09-26 15:02
라인
Researchers discover spreading probability of wet macular degeneration
A study conducted by a local research team has revealed the transmission pr...
by Lee Han-soo
|
2019-09-26 14:23
라인
Ranitidine heartburn drugs banned due to carcinogen risk
The Ministry of Food and Drug Safety has suspended the manufacturing and se...
by Lee Hye-seon
|
2019-09-26 13:32
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit
The government said it would grant insurance benefit to Pfizer’s leukemia t...
by Kim Yun-mi
|
2019-09-26 11:26
라인
'Xtandi emerges as convenient treatment option for prostate cancer patients'
Astellas Korea is strengthening its position in the local prostate cancer m...
by Lee Han-soo
|
2019-09-25 17:39
라인
Korea, Uzbekistan speed up public health cooperation
Korea will accelerate cooperation with Uzbekistan in public health, initiat...
by Kwak Sung-sun
|
2019-09-25 15:26
라인
Ministry to announce results of ranitidine testing for carcinogen
The government is likely to announce the results of the test on ranitidine ...
by Lee Hye-seon
|
2019-09-25 14:46
라인
Helixmith blames hospital for absurd drug mix-up
Helixmith used to be one of the promising biotech firms with its market cap...
by Jeong Sae-im
|
2019-09-25 13:42
라인
NCC develops new chemotherapy to increase survival of osteosarcoma patients
A research team at the National Cancer Center has developed new chemotherap...
by Lee Han-soo
|
2019-09-25 11:48
-
이전
91
92
93
94
95
96
97
98
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top